(Q79707654)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

title

Interleukin 6 is associated with cachexia in patients with prostate cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

author name string

Kenji Kuroda

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Jun Nakashima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Kent Kanao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Akira Miyajima

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Yutaka Horiguchi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Ken Nakagawa

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mototsugu Oya

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Takashi Ohigashi

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Masaru Murai

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

language of work or name

English

0 references

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

volume

69

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

page(s)

113-117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

Cancer anorexia-cachexia syndrome: current issues in research and management

25 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

The Acute Phase Response in the Rodenta

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Interleukin-6: a candidate mediator of human prostate cancer morbidity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Interleukin-6 is an autocrine growth factor in human prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Elevation of cytokine levels in cachectic patients with prostate carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Circulating levels of interleukin-6 in patients with hormone refractory prostate cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Prevention of cancer cachexia by a novel nuclear factor {kappa}B inhibitor in prostate cancer.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Loss of skeletal muscle in cancer: biochemical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Interleukin-6 causes hypocholesterolemia in middle-aged and old rhesus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Serum interleukin-6 and hemoglobin as physiological correlates in the geriatric syndrome of frailty: a pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

The clinical and prognostic significance of erythrocyte sedimentation rate (ESR), serum interleukin-6 (IL-6) and acute phase protein levels in multiple myeloma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Change in Muscle Strength Explains Accelerated Decline of Physical Function in Older Women With High Interleukin-6 Serum Levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

The association of plasma IL-6 levels with functional disability in community-dwelling elderly

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Interleukin-6-deficient mice develop mature-onset obesity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

CNTO 328, a monoclonal antibody to IL-6, inhibits human tumor-induced cachexia in nude mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

Circulating interleukin-6 predicts survival in patients with metastatic breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

The prognostic significance of plasma interleukin-6 levels in patients with metastatic hormone-refractory prostate cancer: results from cancer and leukemia group B 9480.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.UROLOGY.2006.09.039

10.1016/J.UROLOGY.2006.09.039

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17270630%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

1 reference